Report on how AI is redefining market landscape - The global genomics market size is estimated to grow by USD 5.21 billion from 2024-2028, according to Technavio. The market is estimated to grow at a ...
Zacks.com on MSN17h
Is QIAGEN Stock an Apt Pick for Your Portfolio Right Now?QIAGEN N.V.’s QGEN long-term business strategy focuses on forming partnerships for the development, commercialization, marketing and distribution of existing and future products. The company sees ...
“The best figures we can come up with for using these kinds of medications is between a third and 50 per cent of people ...
Piper Sandler analyst David Westenberg lowered the firm’s price target on Myriad Genetics (MYGN) to $14 from $24 and keeps a Neutral rating on ...
The company, founded by 25-year-old Kian Sadeghi, announced a $14 million Series A, bringing its total funding to about $32 million.
AlleyWatch sat down with Nucleus CEO and Founder Kian Sadeghi to learn more about the business, its future plans, and recent ...
A gene-edited mouse with two male parents has survived to adulthood, pushing new progress on stem cell research.
A patient found to carry a BRCA1 pathogenic variant is not referred to a certified genetic counselor in her health system.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback